Abstract
Human T cell leukemia virus type-I (HTLV-1) infection courses with a myelopathy, the tropical spastic paraparesis (HAM/TSP). In a case-control study, we compared the neuropsychological profile and functional characteristics in two case HTLV-1-infected groups (asymptomatic and with HAM/TSP) with a control group negative for HTLV-1. Subjects were paired for age, sex, and educational features. The case group differed from control group in neuropsychological measures such as in episodic memory recall, executive functions, and fine motor dexterity measure. Individuals with HAM/TSP have more depressive symptoms and worst performance in activities of daily living (ADL) presenting a less functionality. In multivariate models, the fine motor performance, the executive functioning, the recognition memory, and the depressive symptoms explained part of the variance in functionality. Those findings may contribute to understand of everyday life impairments and limitations of HTLV-1-infected population and to organize the rehabilitation. Once more, based in neuropsychological and functional data, we can reaffirm that HTLV-1 is never a benign condition, but sometimes it is only in a stage coursing with less symptoms.
Similar content being viewed by others
References
Cartier L, Gormaz A (1999) Subcortical dementia in HTLV-I tropical spastic paraparesis. Study of 43 cases. Rev Med Chil 127(4):444–450
Cervilla JO, Cartier LR, García LF (2006) Resonancia Magnética de médula espinal y cerebro en el correlato clínico de la paraparesia espástica progresiva que se asocia al virus humano linfotrópico tipo-I (HTLV-I). Rev Med Chil 134(8)
Coutinho DJI, Galvão-Castro B, Lima J, Castello C, Eiter D, Grassi MF (2011) Impacto da mielopatia associada ao HTLV/paraparesia espástica tropical (TSP/HAM) nas atividades de vida diária (AVD) em pacientes infectados pelo HTLV-1. Acta Fisiátrica 9;18(1):6–10
Ciccarelli N (2020) Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? Infection 48:37–42
de Paula JJ, Costa DS, Bertola L, Miranda DD, Malloy-Diniz LF (2013) Verbal fluency in older adults with low educational level: what is the role of executive functions and processing speed? Rev Bras Psiquiatr 35(4):440–442
de Paula JJ, Bertola L, de Ávila RT, Assis L d O, Albuquerque M, Bicalho MA, de Moraes EN, Nicolato R, Malloy-Diniz LF (2014) Development, validity, and reliability of the general activities of daily living scale: a multidimensional measure of activities of daily living for older people. Rev Bras Psiquiatr 36(2):143–152
de Paula JJ, Diniz BS, Bicalho MA, Albuquerque MR, Nicolato R, de Moraes EN, Romano-Silva MA, Malloy-Diniz LF (2015) Specific cognitive functions and depressive symptoms as predictors of activities of daily living in older adults with heterogeneous cognitive backgrounds. Front Aging Neurosci 20(7):139.
de Paula JJ, Albuquerque MR, Lage GM, Bicalho MA, Romano-Silva MA, Malloy-Diniz LF (2016) Impairment of fine motor dexterity in mild cognitive impairment and Alzheimer’s disease dementia: association with activities of daily living. Rev Bras Psiquiatr 38(3):235–238
De Castro-Costa CM, Araújo AQC, Barreto MM, Takayanagui OM, Sohler MP, Da Silva ELM, De Paula SMB, Ishak R, Ribas JGR, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP (2006) Proposal for diagnostic criteria of tropical spastic Paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retrovir 22(10):931–935
Dekaban GA, Oger JJF, Foti D, King EE, Waters DJ, Picard FJ, Arp J, Werker D, Rice GPA (1994) HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis. Clin Diagn Virol 2(2):67–78
Dubois B, Slachevsky A, Litvan I, Pillon BFAB (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626
Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E et al (2017) HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol 264(8):1715–1727
Fukushima T, Ikeda T, Uyama E, Uchino M, Okabe H, Ando M (1994) Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM). J Neurol Sci 126(1):30–39
Gascón MRP, Casseb J, Smid J, Vidal JE, Fonseca LAM, Paiva A et al (2017) Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status. J Neurol Sci 377:185–189
Gessain A, Gout O (1992) Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 117(11):933–946
Gonçalves LR, Barbosa LNF, Magalhaes PMR, Rocha-Filho PAS (2017) Characterization of cognitive performance and evaluation of quality of life among patients with HTLV-1. Clin Neurol Neurosurg 160:142–146
Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG (2009) Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev 19(2):186–203
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Heather B, Allen Mccutchan J, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10(03)
Hollsberg P, Hafler DA (1993) Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328(16):1173–1182
Izumo S, Umehara F, Kashio N, Kubota R, Sato E, Osame M (1997) Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). Leukemia 11(3):S82–S84
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1444
Lepoutre V (2009) Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Frontiers in Bioscience 14:1152
Malloy-Diniz LF, Lasmar VAP, Gazinelli L d SR, Fuentes D, Salgado JV (2007) The Rey auditory-verbal learning test: applicability for the Brazilian elderly population. Rev Bras Psiquiatr 29(4):324–329
Martins JVP, Baptista AF, Araújo A de QC (2012) Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis. Arq Neuropsiquiatr 70(4):257–261
Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43(2):250–253
Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S (2001) Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 183(2):197–205
Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987) Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21(2):117–122
Grice KO, Vogel KA, Le V, Mitchell A, Muniz S, Vollmer MA (2003) Adult norms for a commercially available nine hole peg test for finger dexterity. Am J Occup Ther 57(5):570–573
Porto CS, Fichman HC, Caramelli P, Bahia VS, Nitrini R (2003) Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzheimer's disease. Arq Neuropsiquiatr 61(2B):339–345
Ribas JG, de Melo GC (2002) Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy. Rev Soc Bras Med Trop 1(35):4
Romanelli LC, Miranda DM, Carneiro-Proietti AB, Mamede M, Vasconcelos HM, Martins ML et al (2018) Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1 (HTLV-1). PLoS Negl Trop Dis 12(8):e0006720
Rosa DV, Magno LA, Pereira NC, Romanelli LC, Albuquerque MR, Martins ML, de Freitas Carneiro Proietti AB, Nicolato R, Simões e Silva AC, de Miranda DM (2018) Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals. Biomark Med 12(5):447–454
Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The international HIV dementia scale: a new rapid screening test for HIV dementia. Aids 19(13):1367–1374
Schütze M, Romanelli LCF, Rosa DV, Carneiro-Proietti ABF, Nicolato R, Romano-Silva MA, Brammer M, de Miranda DM (2017) Brain metabolism changes in patients infected with HTLV-1. Front Mol Neurosci:10
Sedó MA, de Paula JJ, Malloy-Diniz LF (2015) FDT: Teste dos Cinco Dígitos. Hogrefe Cetepp, São Paulo
Silva MTT (2003) Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls. J Neurol Neurosurg Psychiatry 74(8):1085–1089
Tuppin P, Gessain A, Kazanji M, Mahieux R, Cosnefroy J-Y, Tekaia F, Georges-Courbot M-C, Georges A, de Thé G (1996) Evidence in Gabon for an intrafamilial clustering with mother-to-child and sexual transmission of a new molecular variant of human T-lymphotropic virus type-II subtype B. J Med Virol 48(1):22–32
Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19(2):152–168
Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S (2002) Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP). Blood 99(1):88–94
Yesavage JA (1988) Geriatric depression scale. Psychopharmacol Bull 24(4):709–711
Funding
This study was financed by Brazilian public governmental agencies: CAPES, CNPq, and FAPEMIG.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Paula, J.J., Romanelli, L.C., de Faria, R.C.V. et al. Cognitive impairment in the HTLV-1 infection: a comparative study associated with functional performance. J. Neurovirol. 27, 849–856 (2021). https://doi.org/10.1007/s13365-020-00905-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-020-00905-5